These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 17420342)

  • 1. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
    Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
    Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
    Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
    Castro LR; Verde I; Cooper DM; Fischmeister R
    Circulation; 2006 May; 113(18):2221-8. PubMed ID: 16651469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
    Yuan Z; Hein TW; Rosa RH; Kuo L
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
    Díaz-Troya S; Najib S; Sánchez-Margalet V
    Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP.
    Wang M; Urenjak J; Fedele E; Obrenovitch TP
    Biochem Pharmacol; 2004 Apr; 67(8):1619-27. PubMed ID: 15041479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
    Lee DI; Vahebi S; Tocchetti CG; Barouch LA; Solaro RJ; Takimoto E; Kass DA
    Basic Res Cardiol; 2010 May; 105(3):337-47. PubMed ID: 20107996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides.
    Traish A; Moreland RB; Huang YH; Kim NN; Berman J; Goldstein I
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):131-7. PubMed ID: 10542137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cGMP in sildenafil-induced activation of endothelial Ca2+-activated K+ channels.
    Luedders DW; Muenz BM; Li F; Rueckleben S; Tillmanns H; Waldecker B; Wiecha J; Erdogan A; Schaefer CA; Kuhlmann CR
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):365-70. PubMed ID: 16633077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of the positive dromotropic effect of isoproterenol by adenosine: role of nitric oxide, cGMP-dependent cAMP-phosphodiesterase and protein kinase G.
    Zima A; Martynyuk AE; Seubert CN; Morey TE; Sumners C; Cucchiara RF; Dennis DM
    J Mol Cell Cardiol; 2000 Sep; 32(9):1609-19. PubMed ID: 10966824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
    Whalin ME; Scammell JG; Strada SJ; Thompson WJ
    Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
    Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
    J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures.
    John TA; Ibe BO; Raj JU
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):148-58. PubMed ID: 17892503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
    Park K; Moreland RB; Goldstein I; Atala A; Traish A
    Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.